Cat. No. | Product name | CAS No. |
DC23886 |
GSM-2
GSM-2 is a second-generation γ-secretase modulator (GSM) that only decreases Aβ42 (IC50=65.2 nM), while inversely increasing Aβ38 and having no effect on β-CTF and Aβ40 levels. |
956465-56-8 |
DC20399 |
GSTO1 inhibitor C1-27
GSTO1 inhibitor C1-27 is a potent, selective, covalent glutathione S-transferase omega 1 (GSTO1) inhibitor with IC50 of 31 nM. |
568544-03-6 |
DC20112 |
GT 949
Featured
GT 949 is a selective excitatory amino acid transporter-2 (EAAT2) positive allosteric modulator with an EC50 of 0.26 nM. |
460330-27-2 |
DC21403 |
GTC 365
GTC-365 (NSC 177365) is a small drug-like pharmacological chaperone that induces cancer cell death by restoring tertiary DNA structures in mutant human telomerase reverse transcriptase (hTERT) promoters. |
80261-18-3 |
DC21404 |
GTC 365 hydrochloride
GTC-365 (NSC 177365) is a small drug-like pharmacological chaperone that induces cancer cell death by restoring tertiary DNA structures in mutant human telomerase reverse transcriptase (hTERT) promoters. |
63345-17-5 |
DC21825 |
Guanabenz
Featured
Guanabenz (WY 8678) is an α2 adrenergic receptor agonist that is used as an antihypertensive agent, also has been proposed to exert protective effects against misfolding by interfering with eIF2α-P dephosphorylation through selective disruption of a PP1-P |
5051-62-7 |
DC10233 |
Guanfacine Hydrochloride
Guanfacine Hydrochloride is a selective α2A-adrenoceptor agonist with anti-hypertensive effect. |
29110-48-3 |
DC12076 |
Guanidinosuccinic acid
Guanidinosuccinic acid is a nitrogenous metabolite isolated in excess from serum and urine. |
6133-30-8 |
DC23297 |
GUT-70
GUT-70 is a tricyclic coumarin derived from Calophyllum brasiliense, markedly reduces cell proliferation, viability through G1 cell cycle arrest and increases apoptosis. |
161633-75-6 |
DC23117 |
GV-58
GV-58 is a potent, selective N-Type and P/Q-type Ca2+ Channel agonist with EC50 of 7.2 and 8.8 uM, shows no acitivity for L-type calcium channels (EC50>100 uM). |
1402821-41-3 |
DC9458 |
GW-1100
GW 1100 is a selective antagonist of GPR40-mediated Ca2+ elevations in HEK293 cells stimulated by GW 9508 (an agonist of both GPR40 and GPR120, another GPCR activated by long chain fatty acids) or linoleic acid with a pIC50 value equal to 5.99. |
306974-70-9 |
DC21102 |
GW 275175X
GW 275175X is a derivative of BDCRB that displays anti-HCMV activity by inhibition of viral DNA maturation. |
217950-62-4 |
DC23402 |
GW 841819X
GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain that displays activity in vivo against NUT-midline carcinoma, multiple myeloma, mixed-lineage leukemia, and acute myeloid leukemia.. |
146135-18-4 |
DC7149 |
GW1929
Featured
GW1929 is a synthetic peroxisome proliferator-activated receptor-γ (PPARγ) agonist with IC50 of 6.2 nM and 13 nM for human and mouse, respectively. |
196808-24-9 |
DC23142 |
GW274150
Featured
GW274150 is a novel arginine-competitive, NADPH-dependent iNOS inhibitor that has been identified from a series of acetamide amino acids that have a high selectivity for iNOS vs both eNOS (> 260-fold) and nNOS (> 219-fold) and high bioavailability (> 90%) after oral administration.Target: iNOSin vivo: GW274150 demonstrates a narrow neuroprotective therapeutic window against the toxic actions of 6-OHDA. GW274150 administration leads to a dose-dependent decrease in the number of iNOS-positive cells in the SNc of the 6-OHDA-lesioned animals. The iNOS inhibitor GW274150 fails to produce long-term neuroprotection after its withdrawal in the 6-OHDA-lesioned rat. [1] |
210354-22-6 |
DC8193 |
GW311616A
GW311616A is a potent, intracellular human neutrophil elastase (HNE, α-1-proteinase) inhibitor. |
197890-44-1 |
DC12644 |
GW406108X
GW406108X (GW-406108X, GW108X) is specific inhibitor of Kif15 (Kinesin-12) with IC50 of 0.82 uM in ATPase assays. |
1644443-92-4 |
DC7980 |
GW-6604
Featured
GW6604 is a potent and selective ALK-5 inhibitor with potent anticancer activity. |
452342-37-9 |
DC23530 |
GW-766994 R-form
GW-766994 (GW766994) is a potent, selective, orally available CCR3 antagonist with pKi of 7.86 for inhibiting eotaxin-induced eosinophil chemotaxis in vitro assays. |
408303-44-6 |
DC23531 |
GW-766994
GW-766994 (GW766994) is a potent, selective, orally available CCR3 antagonist with pKi of 7.86 for inhibiting eotaxin-induced eosinophil chemotaxis in vitro assays. |
408303-43-5 |
DC22653 |
GW-8510
Featured
GW-8510 (GW8510) is a potent, selective inhibitor of CDK2 with IC50 of 10 nM. |
222036-17-1 |
DC11993 |
GWJ-A-23
GWJ-A-23 (GWJ-23, GWJ23) is a potent, selective autotaxin inhibitor with Ki of 18 nM, an analog of the known ATX inhibitor S32826 and has improved aqueous solubility compared with the parent compound. |
1351930-95-4 |